Belgium's IBA rises on governance shift, analysts flag PanTera stake potential
BUZZ-Belgium's IBA rises on governance shift, analysts flag PanTera stake potential ** Ion Beam Applications' IBAB.BR stock rises 7%, on track for best day in four weeks, after the Belgian radiation therapy firm announces leadership, board changes
** CEO Olivier Legrain named vice-chairman; deputy CEO Henry de Romrée gets handed operational responsibility for all group activities
** Degroof sees changes as "logical" succession with de Romrée likely next CEO, which KBC Securities agrees with, and Legrain next chairman; Degroof also flags two new directors as step up in board quality
** KBC: PanTera's potential PE exit - reported by Mergermarket - at €1 billion ($1.16 billion) valuation implies €313 mln, or €10.7/share, for IBA's stake, vs KBC's current €3.2/share estimate
** PanTera IPO around 2030 not ruled out; 2028 PE exit possible, though valuation uncertain, broker notes
($1 = €0.8620)
(Reporting by Olivier Cherfan)
Recent news on Ion Beam Applications SA
See all newsBrief: IBA Signs Contract With Government Of Assam For India's State-Run Proton Therapy Center
Brief: Iba Signs Contract For Be Efficient Sterilization Solution In Germany
Brief: IBA Says First Patient Treated In C-Flash-01 Conformalflash Clinical Trial
Brief: IBA Selected To Support The US Expansion Of Radiopharmaceutical Producer
Brief: IBA And Telix Strengthen Ties Through Agreement To Distribute ARTMS QIS